Rising healthcare costs, an aging population, and the COVID-19 pandemic have spurred the rapid expansion of care at home

However, home infusion therapy has yet to fully take shape due to a host of challenges. In a recent survey, CareCentrix interviewed U.S. payors representing Medicare, Commercial, and Medicaid lines of business. The goal was to take a pulse of the marketplace, identify key barriers, and gain insights about the factors shaping the move to home infusion therapy.

Learn what payors revealed about the future of Home Infusion.

Tags
  • Home Infusion Therapy